ПОСТРОЕНИЕ УСПЕШНОЙ ПРОГРАММЫ ПО ЛЕЧЕНИЮ ПЕРИТОНЕАЛЬНОГО КАРЦИНОМАТОЗА
Аннотация
Создание программы по лечению пациентов с перитонеальным карциноматозом - это многоступенчатый и сложный проект. Стратегию построение можно разделить на три этапа: формирование общего видения группой энтузиастов, вовлечение необходимых клинических служб для подготовки к первым операциям, проведение циторедукций с анализом первых данных. Ведение научной работы и обмен данных между центрами и с международным сообществам значительно поможет в успешном развитии проекта.
Литература
1. Абдуллаев А.Г., Давыдов М.И. Современные подходы к лечению псевдомиксомы брюшины // Российский Онкологический Журнал. – 2013. – №5. – С. 4-10.
2. Aletti G.D., et al. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience. // J Am Coll Surg. – 2009. – Vol. 208 (4). – P. 614-620.
3. European School of Peritoneal Surface Oncology (ESPSO). Available from: http://www.essoweb.org/school-of-peritoneal-surface-oncology-es/.
4. Kusamura S. The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs // Surg. Oncol. Clin. N. Am. – 2012. – Vol. 21 (4). – P. 559-576.
5. Kusamura S., Baratti D., Deraco M. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies // Ann. Surg. – 2012. – Vol. 255 (2). – P. 348-356.
6. Kusamura S., et al. Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres. // J Surg Oncol. – 2013. – Vol. 107 (4). – P. 312-319.
7. Li K.Y., et al. Failure to rescue following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. // J Surg Res. – 2017. – Vol. 214. – P. 209-215.
8. Passot G., et al. A Perioperative Clinical Pathway Can Dramatically Reduce Failure-to-rescue Rates After Cytoreductive Surgery for Peritoneal Carcinomatosis: A Retrospective Study of 666 Consecutive Cytoreductions. // Ann Surg. – 2017. – Vol. 265 (4). – P. 806-813.
9. The Peritoneal Surface Oncology Group International. Available from: http://www.psogi.com/.
10. Voron T. Cytoreductive surgery with a hyperthermic intraperitoneal chemotherapy program: Safe after 40 cases, but only controlled after 140 cases. // Eur. J. Surg. Oncol. – 2015. – Vol. 41 (12). – P. 1671-1677.
REFERENCES
1. Abdullaev A.G., Davydov M.I. Sovremennye podhody k lecheniyu psevdomiksomy bryushiny // Rossijskij Onkologicheskij Zhurnal. – 2013. – No 5. – P. 4-10. (in Russian)
2. Aletti G.D., et al. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience. // J Am Coll Surg. – 2009. – Vol. 208 (4). – P. 614-620.
3. European School of Peritoneal Surface Oncology (ESPSO). Available from: http://www.essoweb.org/school-of-peritoneal-surface-oncology-es/.
4. Kusamura S. The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs // Surg. Oncol. Clin. N. Am. – 2012. – Vol. 21 (4). – P. 559-576.
5. Kusamura S., Baratti D., Deraco M. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies // Ann. Surg. – 2012. – Vol. 255 (2). – P. 348-356.
6. Kusamura S., et al. Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres. // J Surg Oncol. – 2013. – Vol. 107 (4). – P. 312-319.
7. Li K.Y., et al. Failure to rescue following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. // J Surg Res. – 2017. – Vol. 214. – P. 209-215.
8. Passot G., et al. A Perioperative Clinical Pathway Can Dramatically Reduce Failure-to-rescue Rates After Cytoreductive Surgery for Peritoneal Carcinomatosis: A Retrospective Study of 666 Consecutive Cytoreductions. // Ann Surg. – 2017. – Vol. 265 (4). – P. 806-813.
9. The Peritoneal Surface Oncology Group International. Available from: http://www.psogi.com/.
10. Voron T. Cytoreductive surgery with a hyperthermic intraperitoneal chemotherapy program: Safe after 40 cases, but only controlled after 140 cases. // Eur. J. Surg. Oncol. – 2015. – Vol. 41 (12). – P. 1671-1677.
2. Aletti G.D., et al. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience. // J Am Coll Surg. – 2009. – Vol. 208 (4). – P. 614-620.
3. European School of Peritoneal Surface Oncology (ESPSO). Available from: http://www.essoweb.org/school-of-peritoneal-surface-oncology-es/.
4. Kusamura S. The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs // Surg. Oncol. Clin. N. Am. – 2012. – Vol. 21 (4). – P. 559-576.
5. Kusamura S., Baratti D., Deraco M. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies // Ann. Surg. – 2012. – Vol. 255 (2). – P. 348-356.
6. Kusamura S., et al. Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres. // J Surg Oncol. – 2013. – Vol. 107 (4). – P. 312-319.
7. Li K.Y., et al. Failure to rescue following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. // J Surg Res. – 2017. – Vol. 214. – P. 209-215.
8. Passot G., et al. A Perioperative Clinical Pathway Can Dramatically Reduce Failure-to-rescue Rates After Cytoreductive Surgery for Peritoneal Carcinomatosis: A Retrospective Study of 666 Consecutive Cytoreductions. // Ann Surg. – 2017. – Vol. 265 (4). – P. 806-813.
9. The Peritoneal Surface Oncology Group International. Available from: http://www.psogi.com/.
10. Voron T. Cytoreductive surgery with a hyperthermic intraperitoneal chemotherapy program: Safe after 40 cases, but only controlled after 140 cases. // Eur. J. Surg. Oncol. – 2015. – Vol. 41 (12). – P. 1671-1677.
REFERENCES
1. Abdullaev A.G., Davydov M.I. Sovremennye podhody k lecheniyu psevdomiksomy bryushiny // Rossijskij Onkologicheskij Zhurnal. – 2013. – No 5. – P. 4-10. (in Russian)
2. Aletti G.D., et al. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience. // J Am Coll Surg. – 2009. – Vol. 208 (4). – P. 614-620.
3. European School of Peritoneal Surface Oncology (ESPSO). Available from: http://www.essoweb.org/school-of-peritoneal-surface-oncology-es/.
4. Kusamura S. The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs // Surg. Oncol. Clin. N. Am. – 2012. – Vol. 21 (4). – P. 559-576.
5. Kusamura S., Baratti D., Deraco M. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies // Ann. Surg. – 2012. – Vol. 255 (2). – P. 348-356.
6. Kusamura S., et al. Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres. // J Surg Oncol. – 2013. – Vol. 107 (4). – P. 312-319.
7. Li K.Y., et al. Failure to rescue following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. // J Surg Res. – 2017. – Vol. 214. – P. 209-215.
8. Passot G., et al. A Perioperative Clinical Pathway Can Dramatically Reduce Failure-to-rescue Rates After Cytoreductive Surgery for Peritoneal Carcinomatosis: A Retrospective Study of 666 Consecutive Cytoreductions. // Ann Surg. – 2017. – Vol. 265 (4). – P. 806-813.
9. The Peritoneal Surface Oncology Group International. Available from: http://www.psogi.com/.
10. Voron T. Cytoreductive surgery with a hyperthermic intraperitoneal chemotherapy program: Safe after 40 cases, but only controlled after 140 cases. // Eur. J. Surg. Oncol. – 2015. – Vol. 41 (12). – P. 1671-1677.
Опубликована
2018-03-24
Как цитировать
ГУЩИН, Вадим Викторович; ДВОРНИЧЕНКО, Виктория Владимировна; ШЕЛЕХОВ, Алексей Владимирович.
ПОСТРОЕНИЕ УСПЕШНОЙ ПРОГРАММЫ ПО ЛЕЧЕНИЮ ПЕРИТОНЕАЛЬНОГО КАРЦИНОМАТОЗА.
Сибирский медицинский журнал (Иркутск) 16+, [S.l.], v. 150, n. 3, p. 61-64, март 2018.
ISSN 1815-7572. Доступно на: <http://smj.ismu.baikal.ru/index.php/osn/article/view/41>. Дата доступа: 25 янв. 2025
Выпуск
Раздел
Лекции
